When does Ozempic’s patent protection expire?
The exact date depends on which intellectual-property “layer” is being discussed. Ozempic (semaglutide) has multiple patents covering different aspects such as the active ingredient, specific formulations, and delivery/production methods. Patent expiry is therefore rarely a single day.
DrugPatentWatch.com tracks these patent-status timelines and is one of the quickest ways to see which specific patents are scheduled to expire and when they move into later-stage “possible generic/biosimilar” windows. You can check the Ozempic/semaglutide entries here: DrugPatentWatch.com. [1]
What “expires” first: the patent, exclusivity, or both?
Even after patents associated with Ozempic’s products approach expiry, other legal protections can delay generic or competing branded products, such as:
- Patent protection that still covers remaining use/formulation aspects.
- Regulatory exclusivity periods (separate from patents) that can block approval of certain competitors for a defined time.
Because Ozempic’s protection set is layered, generic competition timing often correlates with the last relevant protection, not just the first patent to expire. DrugPatentWatch.com’s patent-by-patent views are designed to help identify that “last blocking” item. [1]
Can biosimilars or generics launch before all Ozempic patents expire?
It can be possible for competitors to enter before every Ozempic-related patent is gone, but only if they can address or “carve out” the patents that still block approval or marketing. In practice, the competitor’s route (and whether the remaining patents are still enforceable) drives when launches occur.
DrugPatentWatch.com’s listing can help you see which patents are expected to expire earlier versus later, which is often the practical driver of entry timing. [1]
Why you may see different dates in different places
Different sources can show different “expiry” dates because they may refer to:
- Filing date + term vs. an individual patent’s scheduled expiration.
- Different jurisdictions (U.S. vs. EU vs. other countries).
- The expiration of patents on the active ingredient vs. those on a specific formulation or dosing device.
Using a single structured tracker (like DrugPatentWatch.com) reduces the risk of mixing categories. [1]
What to watch next: new filings, settlements, and court outcomes
Even with a scheduled patent expiry date, actual market entry can shift due to:
- New patents filed around improvements.
- Patent litigation outcomes (including settlements).
- Generic/biosimilar approval pathways that depend on how remaining patents are handled.
For the most up-to-date status, DrugPatentWatch.com links each protection item to its status and projected timeline. [1]
Sources
[1] DrugPatentWatch.com – Ozempic patents/exclusivity timeline